What question did this study set out to answer?

This study aims to evaluate urinary cystatin C as a diagnostic marker for acute kidney injury and sepsis in intensive care unit patients.

May 12, 2010Critical CareOpen Access

Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit

View Full Paper

Ask AI

Bookmark

This study aims to evaluate urinary cystatin C as a diagnostic marker for acute kidney injury and sepsis in intensive care unit patients.
Conducted as a randomized trial registered with ACTRN012606000032550.
Assessed urinary cystatin C levels in patients diagnosed with acute kidney injury and sepsis in the intensive care unit.
Monitored patient outcomes related to mortality.
Urinary cystatin C accurately diagnosed acute kidney injury and sepsis.
Higher levels of urinary cystatin C were associated with increased mortality risk in these patients.

We only have this paper's title and publication details.

Randomized trial identifies urinary cystatin C as a diagnostic marker for mortality in intensive care unit patients, suggesting its clinical utility.

Australian New Zealand Clinical Trials Registry ACTRN012606000032550.

No takes yet. Share an insight, caveat, or question.

Nejat et al. (2010) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized trial identifies urinary cystatin C as a diagnostic marker for mortality in intensive care unit patients, suggesting its clinical utility.

Australian New Zealand Clinical Trials Registry ACTRN012606000032550.